氧化酶类纳米酶的最新进展:机制,预测模型和应用
Xiaoli Wang1,2, Qiao-Zhi Li1, Yuliang Zhao3
1Laboratory of Theoretical and Computational Nanoscience, National Center for Nanoscience and Technology of China, Beijing 100190, China.
ACS applied materials & interfaces
|November 22, 2025
概括
类似氧化酶的纳米酶,具有类似酶活性的纳米材料,在各种领域显示出很大的前景. 这篇评论详细介绍了它们的机制,应用程序和计算设计策略,以便在未来开发.
科学领域:
- 纳米材料科学 科学 纳米材料科学
- 催化剂是一种催化剂.
- 生物化学 生物化学
背景情况:
- 纳米酶是具有类似酶的催化性能的纳米材料.
- 类似氧化酶 (OXD) 的纳米酶已经在各种应用中出现了显著的潜力.
- 这种观点侧重于OXD类纳米酶的最新进展.
研究的目的:
- 系统地审查最近在OXD类纳米酶方面的进展.
- 讨论它们的催化机制,优势和应用.
- 探索用于预测活动和指导设计的计算方法.
主要方法:
- 关于金属,金属氧化物,碳材料,MOF和单原子/双原子催化剂的文献评论.
- 对关键基质的催化机制 (4e-和2e-通路) 的分析.
- 检查第一原则计算和机器学习应用.
主要成果:
- 类似OXD的纳米酶表现出各种类似酶的活动.
- 对TMB,葡萄糖和AA等基质的反应途径进行详细讨论.
- 纳米酶设计和活动预测的计算方法的整合.
结论:
- 类似OXD的纳米酶在治疗,传感和工业中具有广泛的应用.
- 了解催化机制对于优化性能至关重要.
- 计算工具对于加速新型纳米酶的合理设计至关重要.
相关概念视频
Introduction to Mechanisms of Enzyme Catalysis
10.4K
For many years, scientists thought that enzyme-substrate binding took place in a simple "lock-and-key" fashion. This model stated that the enzyme and substrate fit together perfectly in one instantaneous step. However, current research supports a more refined view scientists call induced fit. The induced-fit model expands upon the lock-and-key model by describing a more dynamic interaction between enzyme and substrate. As the enzyme and substrate come together, their interaction causes...
10.4K
Ribozymes
13.3K
The term ribozyme is used for RNA that can act as an enzyme. Ribozymes are mainly found in selected viruses, bacteria, plant organelles, and lower eukaryotes. Ribozymes were first discovered in 1982 when Tom Cech’s laboratory observed Group I introns acting as enzymes. This was shortly followed by the discovery of another ribozyme, Ribonulcease P, by Sid Altman’s laboratory. Both Cech and Altman received the Nobel Prize in chemistry in 1989 for their work on ribozymes.
Ribozymes can...
Ribozymes can...
13.3K
Oxidation and Reduction of Organic Molecules
9.1K
Energy production within a cell involves many coordinated chemical pathways. Most of these pathways are combinations of oxidation and reduction reactions, which occur at the same time. An oxidation reaction strips an electron from an atom in a compound, and the addition of this electron to another compound is a reduction reaction. Because oxidation and reduction usually occur together, these pairs of reactions are called redox reactions.
The removal of an electron from a molecule, results in a...
The removal of an electron from a molecule, results in a...
9.1K
Redox Reactions
58.1K
Oxidation-reduction or redox reactions involve the transfer of electrons from one molecule or atom to another. When an atom gains an electron, another atom must lose an electron, meaning oxidation and reduction must occur together. Since the redox occurs in pairs, the atom that gets oxidized is also called the reducing agent or reductant, and the atom that is reduced is also called the oxidizing agent or oxidant. A straightforward way to remember the definitions of oxidation and reduction is...
58.1K
Catalytically Perfect Enzymes
4.9K
The theory of catalytically perfect enzymes was first proposed by W.J. Albery and J. R. Knowles in 1976. These enzymes catalyze biochemical reactions at high-speed. Their catalytic efficiency values range from 108-109 M-1s-1. These enzymes are also called 'diffusion-controlled' as the only rate-limiting step in the catalysis is that of the substrate diffusion into the active site. Examples include triose phosphate isomerase, fumarase, and superoxide dismutase.
Most enzymes...
Most enzymes...
4.9K
Phase I Oxidative Reactions: Overview
685
Phase I biotransformation, or functionalization, is a crucial chemical process that converts drugs and other xenobiotics into more water-soluble forms, facilitating expulsion from the body. It involves oxidative, reductive, and hydrolytic reactions that add or unveil polar functional groups on lipophilic substrates. Key players in phase I reactions are the mixed-function oxidases. Situated in liver cell microsomes, these enzymes predominantly carry out drug metabolism. They require molecular...
685


